| Joseph William Townley, MD | |
|
8141 W Center Rd, Omaha, NE 68124-3273 | |
| (402) 391-1100 | |
| (402) 391-1233 |
| Full Name | Joseph William Townley |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 8141 W Center Rd, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972533743 | NPI | - | NPPES |
| 91174901813 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 18367 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Consultants Pc | 8729971981 | 6 |
News Archive
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.
New research suggests the growth rate of the brain's cerebral cortex in babies born prematurely may predict how well they are able to think, speak, plan and pay attention later in childhood. The research is published in the October 12, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, has today announced that it will launch gene specific TAL nucleases on February 28, 2011.
Using a pain clinic as a testing ground, researchers at Johns Hopkins have shown that a management process first popularized by Toyota in Japan can substantially reduce patient wait times and possibly improve the teaching of interns and residents.
› Verified 7 days ago
| Entity Name | Eye Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306869532 PECOS PAC ID: 8729971981 Enrollment ID: O20040203000782 |
News Archive
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.
New research suggests the growth rate of the brain's cerebral cortex in babies born prematurely may predict how well they are able to think, speak, plan and pay attention later in childhood. The research is published in the October 12, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, has today announced that it will launch gene specific TAL nucleases on February 28, 2011.
Using a pain clinic as a testing ground, researchers at Johns Hopkins have shown that a management process first popularized by Toyota in Japan can substantially reduce patient wait times and possibly improve the teaching of interns and residents.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph William Townley, MD 8141 W Center Rd, Omaha, NE 68124-3273 Ph: (402) 391-1100 | Joseph William Townley, MD 8141 W Center Rd, Omaha, NE 68124-3273 Ph: (402) 391-1100 |
News Archive
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.
New research suggests the growth rate of the brain's cerebral cortex in babies born prematurely may predict how well they are able to think, speak, plan and pay attention later in childhood. The research is published in the October 12, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, has today announced that it will launch gene specific TAL nucleases on February 28, 2011.
Using a pain clinic as a testing ground, researchers at Johns Hopkins have shown that a management process first popularized by Toyota in Japan can substantially reduce patient wait times and possibly improve the teaching of interns and residents.
› Verified 7 days ago
Dr. Hythem Abouodah, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-2020 | |
Camilla Ruth Parson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 16820 Frances St, Ste 100, Omaha, NE 68130 Phone: 402-933-6600 Fax: 402-933-7123 | |
Dr. Sebastian J Troia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 515 N 98th St, Omaha, NE 68114 Phone: 402-399-9400 Fax: 402-399-8170 | |
Richard H Legge, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7810 Davenport St, Omaha, NE 68114 Phone: 402-397-1626 Fax: 402-397-1286 | |
Ahmad Halawa, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-3255 | |
Dr. Keegan Anthony Harkins, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3902 Leavenworth St, Omaha, NE 68105 Phone: 402-559-2020 | |
Anas L F Yasin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 985540 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1859 |